Guest Post: If we truly want to cure complex diseases, politicians should reject price setting

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The PhRMA blog welcomes guest...
Read More
Post-approval research save lives. Why is Congress trying disincentivize it?

While some in Congress continue to claim the latest drug pricing plan in Washington is “negotiation,” that is far from the truth. The reality is that the current plan gives the government a new...
Read More
Guest post: Congress should not put future innovation at risk

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The PhRMA blog welcomes guest...
Read More
What they’re saying: Patient advocates want to protect Medicare from government interference

For seniors and people with disabilities, Medicare Parts B and D provide important access to lifesaving medicines. Unfortunately, some in Congress are proposing changes to Medicare under the guise of...
Read More
Guest Post: A patient’s story of the long-term health impacts of COVID-19

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The PhRMA blog welcomes guest...
Read More
The patient perspective navigating COVID-19

As PhRMA members work around the clock to combat COVID-19, the pandemic has had a tremendous impact around the globe. But for those patients who are currently impacted by a health care condition,...
Read More
Guest post: H.R.3 is the wrong approach to help patients like me

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Guest post: Sharing discounts and rebates is the right thing to do

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Guest Post: Following my stroke, having access to ground-breaking medical innovation has never been more important

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
"If Washington isn’t careful, we might leave innovation behind"

“Trying to make medications more affordable is important, but if Washington isn’t careful, we might leave innovation behind.” This is the message we heard from Amy, a Voters for Cures advocate from...
Read More